The circITCH/miR-660/TFCP2 axis is involved in melanoma progression hence circITCH can be a diagnostic biomarker as well as a target for treating melanoma.
circITCH suppresses cell proliferation and metastasis through miR-660/TFCP2 pathway in melanoma.